ILMN Jan 2025 220.000 call
- PR Newswire
Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments.
- Investing.com
Futures lower, JOLTS ahead, GameStop surges - what's moving markets
Investing.com -- U.S. stock futures slip following a volatile session on Monday. Traders are looking ahead to the release of key job openings data, which could provide a fresh glimpse into the state of the U.S. labor market. GameStop (NYSE:GME) shares move higher in after-hours trading, suggesting an extension in a Monday rally in the videogame retailer that was fueled by the return of stock influencer Keith Gill to social media website Reddit.
- Reuters
Illumina's board approves to spin off Grail in June
Shareholders will receive one common share of Grail for every six shares of Illumina, which will retain a 14.5% stake in the unit after the spinoff on June 24. Shares of Illumina were up 4% in extended trading. The gene sequencing machine maker founded Grail and spun it off in 2016, but re-acquired it in 2021 for $7.1 billion to enter the cancer early-detection market.
